| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.38 | 1e-17 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.37 | 3e-16 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.32 | 3e-12 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.3 | 6e-11 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.44 | 1e-10 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-10 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.26 | 2e-10 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-10 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.29 | 8e-10 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.3 | 1e-09 |